1. Home
  2. SANA vs ATEC Comparison

SANA vs ATEC Comparison

Compare SANA & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$3.22

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$11.68

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANA
ATEC
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
SANA
ATEC
Price
$3.22
$11.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$7.60
$22.00
AVG Volume (30 Days)
2.6M
2.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
17.24
15.04
EPS
N/A
N/A
Revenue
N/A
$101,739,000.00
Revenue This Year
N/A
$18.97
Revenue Next Year
N/A
$16.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$9.25
52 Week High
$6.55
$23.29

Technical Indicators

Market Signals
Indicator
SANA
ATEC
Relative Strength Index (RSI) 47.85 44.46
Support Level $3.16 $10.21
Resistance Level $3.36 $13.08
Average True Range (ATR) 0.22 0.55
MACD 0.06 0.06
Stochastic Oscillator 72.67 46.90

Price Performance

Historical Comparison
SANA
ATEC

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Share on Social Networks: